The Votes Are In!
2024 Readers' Choice is back, bigger and better than ever!
View Winners → Health Sep 20, 2024
Photo by Towfiqu barbhuiya on Unsplash
by
share with
By Suzanne Potter, Producer, Public News Service
Hundreds of thousands of older Californians will see huge savings on prescription drugs starting in January, according to a new report from AARP.
The Biden administration’s Inflation Reduction Act caps prescription drug costs at $2,000 per year for people on Medicare, starting in 2025.
Nina Weiler-Harwell, associate director of advocacy and community engagement for AARP California, said an estimated 271,000 people in the Golden State will hit the out-of-pocket maximum next year.
“Medicare drug plan enrollees nationwide who reach the new out-of-pocket cap will see an average savings of roughly $1,500,” said Weiler-Harwell, “or 56% in 2025 for new prescription drugs.”
On average, 40% of people on Medicare who reach the cap will save at $1,000 a year. And 12% will see savings of more than $3,000.
Every year from 2025 to 2029, between 3 and 4 million Part D plan enrollees are estimated to benefit from the new out-of-pocket cap.
Weiler-Harwell said the Inflation Reduction Act introduced a number of new policies to cut costs for Americans on Medicare.
“Copays for insulin capped at $35 a month,” said Weiler-Harwell. “Vaccines such as shingles and pneumonia are free. The Inflation Reduction Act did allow Medicare to negotiate the price of high-cost prescription drugs. But we won’t really start to see that until 2026.”
Also thanks to the IRA, drug companies will have to pay a penalty if they raise their prices higher than inflation.
Disclosure: AARP California contributes to Public News Service’s fund for reporting on Health Issues, Senior Issues. If you would like to help support news in the public interest, visit https://www.publicnewsservice.org/dn1.php.
